Adrialdo José Santos

Adrialdo José Santos

Auto-generated profile, based on publicly available information

Adrialdo José Santos

Universidade Federal de São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2004 in Journal of Neurosurgery
Verified
Journal Article
Closed access
AJAntonio CARLOS MARTINS Maia Jr
Antonio CARLOS MARTINS Maia Jr
SMSuzana M. F. Malheiros
Suzana M. F. Malheiros
ARAntonio J. da Rocha
Antonio J. da Rocha
JSJoão N. Stávale
João N. Stávale
IGIara F. Guimarães
Iara F. Guimarães
FFFernando A. P. Ferraz
Fernando A. P. Ferraz
Object. The diagnosis of low-grade glioma (LGG) cannot be based exclusively on conventional magnetic resonance (MR) imaging studies, and target selection for stereotactic biopsy is a crucial issue given the high risk of sampling errors. The authors hypothesized that perfusion-weighted imaging could provide information on the microcirculation in presumed supratentorial LGGs. Methods. All adult patients with suspected (nonenhancing) supratentorial LGGs on conventional MR imaging between February 2001 and February 2004 were included in this study. Preoperative MR imaging was performed using a dynamic first-pass gadopentate dimeglumine—enhanced spin echo—echo planar perfusion-weighted sequence, and the tumors' relative cerebral blood volume (rCBV) measurements were expressed in relation to the values observed in contralateral white matter. In patients with heterogeneous tumors a stereotactic biopsy was performed in the higher perfusion areas before resection. Among 21 patients (16 men and five women with a mean age of 36 years, range 23–60 years), 10 had diffuse astrocytomas (World Health Organization Grade II) and 11 had other LGGs and anaplastic gliomas. On perfusion-weighted images demonstrating heterogeneous tumors, areas of higher rCBV focus were found to be oligodendrogliomas or anaplastic astrocytomas on stereotactic biopsy; during tumor resection, however, specimens were characterized predominantly as astrocytomas. Diffuse astrocytomas were associated with significantly lower mean rCBV values compared with those in the other two lesion groups (p < 0.01). The rCBV ratio cutoff value that permitted better discrimination between diffuse astrocytomas and the other lesion groups was 1.2 (80% sensitivity and 100% specificity). Conclusions. Perfusion-weighted imaging is a feasible method of reducing the sampling error in the histopathological diagnosis of a presumed LGG, particularly by improving the selection of targets for stereotactic biopsy.

19 June 2003 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
SMS. M. F. Malheiros
S. M. F. Malheiros
HCH. Carrete
H. Carrete
JSJ. N. Stávale
J. N. Stávale
ASA. J. Santos
A. J. Santos
LBL. R. R. Borges
L. R. R. Borges
AGA. A. Gabbai
A. A. Gabbai

1 December 2002 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
SMSuzana M.F. Malheiros
Suzana M.F. Malheiros
CFClélia M.R. Franco
Clélia M.R. Franco
JSJoão N. Stávale
João N. Stávale
ASAdrialdo J. Santos
Adrialdo J. Santos
LBLia R.R. Borges
Lia R.R. Borges
AGAlberto A. Gabbai
Alberto A. Gabbai

1 February 2015 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
LLLuiz Victor Maia Loureiro
Luiz Victor Maia Loureiro
LPLucíola de Barros Pontes
Lucíola de Barros Pontes
DCDonato Callegaro-Filho
Donato Callegaro-Filho
LKLudmila de Oliveira Koch
Ludmila de Oliveira Koch
EWEduardo Weltman
Eduardo Weltman
SMSuzana Maria Fleury Malheiros
Suzana Maria Fleury Malheiros
Objective To evaluate the effect of waiting time (WT) to radiotherapy (RT) on overall survival (OS) of glioblastoma (GBM) patients as a reliable prognostic variable in Brazil, a scenario of medical disparities. Method Retrospective study of 115 GBM patients from two different health-care institutions (one public and one private) in Brazil who underwent post-operative RT. Results Median WT to RT was 6 weeks (range, 1.3-17.6). The median OS for WT ≤ 6 weeks was 13.5 months (95%CI , 9.1-17.9) and for WT > 6 weeks was 14.2 months (95%CI, 11.2-17.2) (HR 1.165, 95%CI 0.770-1.762; p = 0.470). In the multivariate analysis, the variables associated with survival were KPS (p < 0.001), extent of resection (p = 0.009) and the adjuvant treatment (p = 0.001). The KPS interacted with WT to RT (HR 0.128, 95%CI 0.034-0.476; p = 0.002), showing that the benefit of KPS on OS depends on the WT to RT. Conclusion No prognostic impact of WT to RT could be detected on the OS. Although there are no data to ensure that delays to RT are tolerable, we may reassure patients that the time-length to initiate treatment does not seem to influence the control of the disease, particularly in face of other prognostic factors.

23 January 2014 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
LLLuiz Victor Maia Loureiro
Luiz Victor Maia Loureiro
LPLucíOla de Barros Pontes
LucíOla de Barros Pontes
DCDonato Callegaro-Filho
Donato Callegaro-Filho
LKLudmila de Oliveira Koch
Ludmila de Oliveira Koch
EWEduardo Weltman
Eduardo Weltman
SMSuzana Maria Fleury Malheiros
Suzana Maria Fleury Malheiros
The aim of this study was to describe the epidemiological and survival features of patients with glioblastoma multiforme treated in 2 health care scenarios—public and private—in Brazil. We retrospectively analyzed clinical, treatment, and outcome characteristics of glioblastoma multiforme patients from 2003 to 2011 at 2 institutions. The median age of the 171 patients (117 public and 54 private) was 59.3 years (range, 18–84). The median survival for patients treated in private institutions was 17.4 months (95% confidence interval, 11.1–23.7) compared with 7.1 months (95% confidence interval, 3.8–10.4) for patients treated in public institutions (P < .001). The time from the first symptom to surgery was longer in the public setting (median of 64 days for the public hospital and 31 days for the private institution; P = .003). The patients at the private hospital received radiotherapy concurrent with chemotherapy in 59.3% of cases; at the public hospital, only 21.4% (P < .001). Despite these differences, the institution of treatment was not found to be an independent predictor of outcome (hazard ratio, 1.675; 95% confidence interval, 0.951–2.949; P = .074). The Karnofsky performance status and any additional treatment after surgery were predictors of survival. A hazard ratio of 0.010 (95% confidence interval, 0.003–0.033; P < .001) was observed for gross total tumor resection followed by radiotherapy concurrent with chemotherapy. Despite obvious disparities between the hospitals, the medical assistance scenario was not an independent predictor of survival. However, survival was directly influenced by additional treatment after surgery. Therefore, increasing access to resources in developing countries like Brazil is critical.

1 January 2020 in World Neurosurgery
Verified
Journal Article
Closed access
Giovanni BoschettiGiovanni Boschetti
Giovanni Boschetti
ASAdrialdo Jose Santos
Adrialdo Jose Santos
KFKellen Paiva Fermon
Kellen Paiva Fermon
GHGustavo Lopes de Freitas Honório
Gustavo Lopes de Freitas Honório
GBGabriel Batistella
Gabriel Batistella
SMSuzana Maria Fleury Malheiros
Suzana Maria Fleury Malheiros